🟢 XBI is trading 3.7% up today as biotech rally extends

XBI is trading 3.7% up at $145.76 in pre-market, extending a strong multi-day rally in biotech names.

• The move appears driven by continued sector momentum and investor interest in higher-beta healthcare exposure, with no fresh ETF-specific headlines or filings overnight.
• Broader index futures are trading slightly lower, suggesting the strength in XBI is sector-specific rather than macro-driven.